Medical weight loss is a physician-supervised approach to losing weight that focuses on the patient's overall health, addressing the root causes of obesity. This process often includes personalized diet and exercise plans, behavioral counseling, and medications or treatments tailored to the individual's needs. Unlike commercial weight loss programs, medical weight loss is designed to manage not only weight but also underlying conditions like diabetes, hypertension, and high cholesterol, with a goal of improving long-term health outcomes.
Semaglutide is a medication used to help manage type 2 diabetes and support weight loss in patients with obesity. It works by mimicking a hormone called GLP-1, which helps regulate blood sugar levels and appetite. For patients with diabetes, semaglutide can improve blood sugar control and reduce the risk of cardiovascular complications. When used for weight management, it helps patients feel fuller, reducing the urge to overeat. Semaglutide is typically administered as a weekly injection, offering a convenient and effective option for patients who need long-term support in managing their health.
Tirzepatide is a newer medication primarily used for type 2 diabetes management, but it has gained significant attention for its weight loss benefits, often surpassing other treatments like semaglutide. Both medications are GLP-1 receptor agonists, but tirzepatide has the added advantage of mimicking another hormone, GIP, which enhances its impact on reducing appetite and increasing metabolism. Studies have shown that tirzepatide can lead to greater weight loss compared to semaglutide, with some patients losing up to 20% of their body weight. This makes tirzepatide an attractive option for individuals seeking more substantial weight reduction, especially those who haven’t achieved their desired results with semaglutide.